Funding profile · Practice operations software
Care GP
An Australian company that names two backers and an accelerator batch but no dollar figures, no priced round, and no SEC Form D. Here is what can and cannot be checked about its capital so far.
Data as of September 25, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 2024 to 2025 | Pre-seed backing | Not disclosed | Startmate Ventures, described in company materials as the pre-seed investment arm of Blackbird Ventures | Company-stated |
| By Oct 2025 | Angel investment | Not disclosed | Ryan Vo, CEO of Nuvo Health, described as both an investor and an early customer | Company-stated |
| 2026 | Y Combinator, Summer 2026 batch | Not disclosed; YC’s standard batch terms are not stated for this company | Y Combinator | YC company page |
What the record shows
No SEC Form D notice was found under Care GP’s name in EDGAR full text search, and none was expected: Care GP is an Australian company, and a Form D is a US filing required only when an issuer sells securities to US investors under Regulation D. The company’s own materials describe “early-stage investment” that has “enabled the company to strengthen technical infrastructure and accelerate deployment timelines,” without a round name, a date, or an amount. Two backers are named across company and accelerator materials: Ryan Vo, an angel investor who is also chief executive of Nuvo Health and, by the company’s account, an early Care GP customer, and Startmate Ventures, which the company describes as the pre-seed arm of Blackbird Ventures. Care GP also appears as a member of Y Combinator’s Summer 2026 batch, an accelerator investment that typically comes with a small, standardized check, though Y Combinator’s own page for the company does not state an amount.
Reading the record
- No amount survives contact with any of the four sources checked.The Yahoo Finance, Cantech Letter, National Law Review and MobiHealthNews coverage, plus the Startmate accelerator profile and the company’s own website, all describe investment in qualitative terms only: “early-stage,” “backing,” “investor.” None gives a dollar figure for any round.
- An investor is also a customer.Ryan Vo is described as both an angel investor in Care GP and, through his role as CEO of Nuvo Health, an early user of the product. That overlap is disclosed by the company itself and is not unusual for healthcare startups that raise from operators in the field, but it means his endorsement in company materials is not a fully independent customer reference.
- The accelerator math does not appear.Y Combinator batches typically involve a standard, small investment for a fixed equity stake, but neither Y Combinator’s company page nor Care GP’s own materials states that figure for this company, so it cannot be added to the total here.
- An Australian raise leaves no US paper trail.Companies that raise only from Australian or other non-US investors, or that raise under an exemption other than Regulation D, file no Form D. The absence of a filing is therefore not evidence that no money moved, only that this research could not independently size it.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Customer base | 150+ GP clinics as of October 2025, zero reported churn, targeting 600+ new customers by December 2026. | Company-stated |
| Unit economics | Average contract value of US$5,000 per customer, expected to rise as more agents launch. | Company-stated |
| Profitability claim | Company says it reached profitability within six months of launch (by around October 2025). No financial statements found to verify. | Company-stated |
| Integration | Live integration with Best Practice’s BP Premier confirmed on Best Practice’s own partner page; MedicalDirector integration described by the CEO as underway. | Third-party confirmation |
| Named reference | Jonathan Lee, owner of Maxim Family Medical, independently confirmed as a customer. | Independent |
What to watch
- A first SEC Form D, which would apply only if Care GP later sells to US investors.
- Any Australian capital raise disclosure, priced round name, or dollar figure from the company or the press.
- Whether Y Combinator’s standard batch investment for Care GP is disclosed.
- Revenue or customer-count figures independently verified beyond the company’s own releases.
The Care GP story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- IndependentCare GP: AI agents to run primary healthcare operations
- IndependentScaling agentic AI for Aussie GPs
- IndependentFrom Sabbatical to Super Agents: How Care GP is Building the AI Enabled Future of Healthcare Provider Ops
- IndependentCare GP – Best Practice partner listing
- CompanyCare GP Scales AI-Powered Healthcare Operations Platform to Reach 7,000 General Practices
- CompanyCare GP to scale Agentic AI for Healthcare Ops to 7,000 GP clinics nationally
- CompanyCare GP website
Compiled from SEC and other public records and published reports as of September 25, 2026. No SEC Form D notice was found under Care GP’s name; this page instead relies on company and accelerator statements, which are labeled throughout. Healthcare Venture Capital Fund holds no position in Care GP. This page is not an offer to sell or a recommendation to buy any security.